An iCD Research report in association with Pharmaceutical Business Review:
What The Global Pharmaceutical Industry
Is Planning In 2010-2011: Procurement,
Investment And Industry Trends Outlook
Reference Code: ICDR1049
Publication Date: JANUARY 2010
What The Global Pharmaceutical Industry Is Planning In 2010-2011: ICDR1049 / JANUARY 2010
Procurement, Investment and Industry Trends Outlook
© ICD Research. This brief is a licensed product and is not to be photocopied Page (1)
Table of Contents
1 Table Of Contents
1 Table Of Contents 2
1.1 List Of Tables 5
1.2 List Of Figures 9
2 Introduction 12
2.1 What Is This Report About? 12
2.2 Methodology 12
2.3 Profile Of Survey Respondents 13
3 Executive Summary 17
3.1.1 The Pharmaceutical Industry Is Very Optimistic About Revenue Growth in 2010 17
3.1.2 The Pharmaceutical Industry Is Optimistic About Market Growth In The US, Canada And
Singapore, Taiwan and Hong Kong 17
3.1.3 Pharmaceutical Companies Will Be Increasing Procurement Spend Over The Next 12 Months
And Have Strict Cost Savings Targets 17
3.1.4 Industry Players Face Key Challenges In Cost Containment, Pricing Pressures and Rising
Competition 18
3.1.5 Suppliers Must Update Their Knowledge Of Buyer Needs In The Areas Of Quality And Service
Levels 18
3.1.6 Buyers Are Adopting Various Risk Mitigation Methods To Maintain Business Continuity 18
4 Industry Dynamics 19
Key findings: 19
4.1 Revenue Growth Expectations In The Global Pharmaceutical Industry 19
4.2 Future Developments In Competitive Structure In The Industry 26
4.3 Merger and Acquisition Activity Predictions 29
5 Pharmaceutical Market Growth Outlook 33
Key findings: 33
5.1 Regional Growth Forecasts In The Pharmaceutical Industry By Country 33
What The Global Pharmaceutical Industry Is Planning In 2010-2011: ICDR1049 / JANUARY 2010
Procurement, Investment and Industry Trends Outlook
© ICD Research. This brief is a licensed product and is not to be photocopied Page (2)
Table of Contents
5.2 Market Growth Forecasts By Industry Sector 42
6 Threats And Opportunities For The Pharmaceutical Industry 51
Key findings: 51
6.1 Leading Business Concerns For The Period 2010-2011 51
6.2 Key Actions To Overcome Business Threats: Cost Management 56
6.3 Key Actions To Overcome Business Threats: Driving Sales 59
6.4 Key Supplier Actions To Maintain And Win Buyer Business 61
7 Pharmaceutical Industry Buyer Spend Activity 69
Key findings: 69
7.1 Annual Procurement Budgets 69
7.2 Procurement Cost Saving Targets In The Pharmaceutical Industry 75
7.3 Planned Change In Procurement Spend 82
7.4 Planned Change In Procurement Spend By Product And Service Category 89
8 Procurement Behaviors And Strategies 97
Key findings: 97
8.1 Critical Success Factors For Supplier Selection 97
8.2 Expected Future Changes In Procurement Objectives 104
8.3 Areas Of Future Value Creation In Procurement Strategy 108
8.4 Mitigating Supplier Failure And Maintaining Business Continuity 116
8.5 Planning Against Business Supply Contingencies 120
9 Appendix 124
9.1 Survey Results: Closed Questions 124
9.2 Methodology 131
What The Global Pharmaceutical Industry Is Planning In 2010-2011: ICDR1049 / JANUARY 2010
Procurement, Investment and Industry Trends Outlook
© ICD Research. This brief is a licensed product and is not to be photocopied Page (3)
Table of Contents
9.3 Contact Us 131
9.4 About ICD Research 131
9.5 Disclaimer 131
What The Global Pharmaceutical Industry Is Planning In 2010-2011: ICDR1049 / JANUARY 2010
Procurement, Investment and Industry Trends Outlook
© ICD Research. This brief is a licensed product and is not to be photocopied Page (4)
Table of Contents
1.1 List Of Tables
Table 1: Count Of Global Pharmaceutical Industry Survey Respondents By Company Type (Number Of
Respondents), 2010 Industry Survey ...................................................................................................................................... 13
Table 2: Buyer Respondents By Organization’s Global Turnover (% Buyer Respondents), Global Pharmaceutical
Industry, 2010 ............................................................................................................................................................................. 13
Table 3: Buyer Respondents By Job Role (% Buyer Respondents), Global Pharmaceutical Industry, 2010.................14
Table 4: Buyer Respondents By Organization’s Total Employee Size (% Buyer Respondents), Global Pharmaceutical
Industry, 2010 ............................................................................................................................................................................. 14
Table 5: Buyer Respondents By Region (% Buyer Respondents), Global Pharmaceutical Industry, 2010....................15
Table 6: Supplier Respondents By Job Role (% Supplier Respondents), Global Pharmaceutical Industry, 2010 ........15
Table 7: Supplier Respondents By Organization’s Global Turnover (% Supplier Respondents), Global
Pharmaceutical Industry, 2010 ................................................................................................................................................ 16
Table 8: Supplier Respondents By Organization's Total Employee Size (% Supplier Respondents), Global
Pharmaceutical Industry, 2010 ................................................................................................................................................ 16
Table 9: Supplier Respondents By Region (% Supplier Respondents), Global Pharmaceutical Industry, 2010 ...........16
Table 10: Company Revenue Growth Optimism Trend By Global Pharmaceutical Industry Company Type:
Pharmaceutical Manufacturers, CRO / CMO Companies, Pharmaceutical Industry Suppliers, Pharmaceutical
Industry Suppliers (% All Respondents), 2009-2010 ............................................................................................................ 20
Table 11: Company Revenue Growth Optimism Trend In The Global Pharmaceutical Industry By Region: North
America, Europe, Asia Pacific, Rest Of The World (% All Respondents), 2009-2010..................................................... 23
Table 12: Company Revenue Growth Optimism In The Global Pharmaceutical Industry By Turnover (% All
Respondents), 2010 .................................................................................................................................................................. 25
Table 13: Pharmaceutical Manufacturer Industry: Market Predictions Of The Fastest And Slowest Growing Regions (%
Pharmaceutical Manufacturer Respondents), 2010 ............................................................................................................. 36
Table 14: CRO / CMO Industry: Market Predictions Of The Fastest And Slowest Growing Regions (% CRO / CMO
Company Respondents), 2010 ................................................................................................................................................ 39
Table 15: Pharmaceutical Industry Supplier Industry: Market Predictions Of The Fastest And Slowest Growing
Regions (% Pharmaceutical Industry Supplier Respondents), 2010.................................................................................. 41
Table 16: Pharmaceutical Manufacturer Predictions Of The Fastest And Slowest Growing Industry Sectors (%
Pharmaceutical Manufacturer Respondents), 2010 ............................................................................................................. 44
Table 17: CRO / CMO Company Predictions Of The Fastest And Slowest Growing Industry Sectors (% CRO / CMO
Company Respondents), 2010 ................................................................................................................................................ 46
Table 18: Pharmaceutical Industry Supplier Predictions Of The Fastest And Slowest Growing Industry Sectors (%
Pharmaceutical Industry Supplier Respondents), 2010 ....................................................................................................... 48
Table 19: Global Pharmaceutical Industry Predictions Of The Fastest And Slowest Growing Industry Sectors By
Region: North America, Europe, Asia Pacific, Rest Of The World (% 'Very Strong Growth' And 'Strong Growth'
Combined, All Respondents), 2010......................................................................................................................................... 50
Table 20: Pharmaceutical Manufacturer Vs. CRO / CMO Company Vs. Pharmaceutical Industry Supplier: Leading
Business Concerns For The Period 2010-2011 Among Global Pharmaceutical